This opportunity is no longer accepting applications.
grant PAR-22-103

Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (UT1/UT2 Clinical Trial Optional)

This grant opportunity is for small businesses working on developing therapeutic agents to treat alcohol use disorder and related organ damage. Eligible applicants should have a therapeutic candidate with strong initial data ready for further development. Projects can focus on various stages, from drug discovery to early clinical trials. For small molecules, compounds need proof of pharmacolog…

This Funding Opportunity Announcement (FOA) supports Small Business Technology Transfer (STTR) applications from small business concerns (SBCs) that propose the development of therapeutic agents for the treatment of alcohol use disorder (AUD) and/or alcohol associated organ damage (AAOD). As a s…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute on Alcohol Abuse and Alcoholism
Program: SBIR

Dates

Opportunity Released: January 21, 2022
Open for Submission: January 21, 2022
Submission Deadline: December 4, 2024
Application Window Closes: December 4, 2024

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.